Petpace Collar Facilitates Activity Restriction in Heartworm Patient

External BlogDogs, Heartworm, Pet Health, Pet Health Monitor, PetPace, PetPace News, Wearable tech

PetPace, the provider of an innovative I0Tcollar for remote real-time monitoring and analysisof pet vital signs andactivity, today released the findings of a new medical case study. Thecase study,available for download here, documents in detail how thePetPace collar facilitated the successful treatmentof a three-year-oldAmerican Pit Bull from a dangerous heartworm (Dirofilaria immitis)parasitic infection.
The patient, named Jimmy, was diagnosed with a heartworm infection – aserious and potentially fatal condition. The parasite lives in the heart,lungs and surrounding blood vessels, and can causesevere lung disease,heart failure and organ damage. According to the American HeartwormSociety, during treatment for heartworm it is essential that patient activitybe minimized in order to decrease chances of fatalcomplications. Despitethis, restricting the activity of a dog for the weeks or months of treatmentis extremely challenging.
Following initial medical treatment, aPetPace smart collarwas appliedto Jimmy to monitor adherence with prescribed activity limitations, and todetect development of potential complications fromthe treatment. Thenon-invasive PetPace monitoring collar improves pethealth and well-beingby wirelessly tracking vital signs and a range of physical and behavioralparameters. The data gathered by the PetPace collar, as well as real-timealerts of critical health issues, are readily available to both owners andcaregivers via a smartphone application.
The PetPace collar closely tracked Jimmy’s daily activity. To assist hisowner in maintaining the activity restriction, an alert for activity above apre-determined threshold was defined in the PetPacemonitoring systemby Jimmy’s veterinarian. Any activity above that level generated an alert,which was sent to the owner.
Following the receipt of PetPace alerts for high activity, and the owner’sconscientious handling of them, Jimmy’s average daily activity levelsclearly declined, as can be seen in the graph below. Before activation ofthe alerts feature, Jimmy spent over 7% of the dayactive. After PetPacealerts activation, that number was down to less than 4% – a decrease ofover 50%.
The PetPace wearable device is intended to provide key clinical insights,meaningful owner engagement and improved compliancewith medicalinstructions after discharge from the hospital, said Dr. Asaf Dagan, aspecialist in canine and feline medicine and surgery, and PetPace’s ChiefVeterinarian. Jimmy’s case demonstrates an effective use of PetPacecollar to help prevent a potentially fatal situation. This principle can beapplied to other conditions in which activity restriction is recommended,he concluded.
“Until now, veterinarians had no effective way of knowing if the patient istruly resting at home as we instructed, noted Dr.Dick Hay, a Diplomateof the American Board of Veterinary Practitioners.The PetPacetechnology allows us, for the first time, to work together with the ownersto achieve the common goal, he continued.
About PetPace
PetPace was founded in 2012 to bring peace of mindto pet owners andprevent unnecessary pain and suffering for dogs andcats throughimproved pet health and quality of life. PetPace specializes in the remotemonitoring of pet vital signs by utilizing advancedanalytical methods andalerting models. The company’s low power, wirelesscollar is fitted with anarray of sensors that report abnormal vital signs within establishedphysiological and behavioral parameters. Once an abnormal sign orbehavior is detected, a sophisticated Cloud-based analytical engineevaluates the signs and if needed, sends an immediate alert regardingany suspected condition. This allows the owner or the vet to take pre-emptive action to protect the pet’s health. For more information aboutPetPace real-time pet health monitoring, visit